# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-012806
Filing Date
2023-04-14
Accepted
2023-04-14 09:00:55
Documents
3
Period of Report
2023-06-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | idya-def_14a-2023.htm | DEF 14A | 949651
2 | GRAPHIC | img11151858_0.jpg | GRAPHIC | 624007
3 | GRAPHIC | img11151858_1.jpg | GRAPHIC | 195636
| Complete submission text file | 0000950170-23-012806.txt |  | 2079253

Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38915 | Film No.: 23819896
SIC: 2834 Pharmaceutical Preparations